Answers are grounded in this paper and cite their sources.
Literature review highlights tranexamic acid's efficacy and safety in treating melasma and PIH, indicating a promising therapeutic option.
Tranexamic acid represents a promising and well-tolerated therapeutic option for hyperpigmentation disorders. Its efficacy across multiple administration routes, favorable safety profile, and synergistic potential with existing therapies support its expanding role as both a primary and adjunctive treatment in dermatologic pigment management.
No takes yet. Share an insight, caveat, or question.
AlJabr et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: